Progesterone 300mg Dosing for Luteal Phase Support
For luteal phase support in IVF/ART cycles, progesterone 300 mg daily can be administered orally (micronized progesterone) in divided doses or as a single daily dose, typically starting within 24 hours after embryo transfer and continuing until pregnancy test or through early pregnancy if positive.
Route and Schedule
The 300 mg dose of micronized progesterone for luteal phase support is administered orally 1, 2, 3. Based on the available evidence:
Oral Administration
- Standard regimen: 300 mg daily as a single dose or divided (e.g., 100 mg three times daily)
- Timing: Begin within 24 hours after embryo transfer
- Duration: Continue until pregnancy test (day 12-14), then through day 30 or longer if pregnancy is confirmed 1, 2
Comparative Context
The evidence shows that oral micronized progesterone 300 mg daily is equivalent in efficacy to vaginal progesterone 90 mg daily for luteal phase support 1, 2. In head-to-head trials:
- Pregnancy rates at day 12: oral 300 mg (29.9%) vs vaginal 90 mg (35.3%), not significantly different (p=0.55)
- Clinical pregnancy rates at day 30: oral 300 mg (25%) vs vaginal 90 mg (28.5%), not significantly different (p=0.61)
- Delivery rates: oral 300 mg (22.2%) vs vaginal 90 mg (23.0%), not significantly different 1, 2
The oral route requires a higher dose (300 mg vs 90 mg vaginal) due to first-pass hepatic metabolism, but achieves comparable clinical outcomes 1, 2.
Important Caveats
Drowsiness is significantly more common with oral progesterone 300 mg compared to vaginal administration 1, 2. Counsel patients to take the medication at bedtime if drowsiness occurs.
Mid-Luteal Dose Adjustment
Recent evidence suggests that increasing the dose from 200 mg to 300 mg at mid-luteal phase (day 7 post-transfer) does not improve pregnancy outcomes in patients with low serum progesterone levels 4. If starting at 200 mg daily, there is no benefit to escalating to 300 mg based on mid-luteal progesterone measurements.
Alternative Formulations
- Vaginal progesterone: 90-200 mg daily is an alternative with less systemic side effects 1, 2
- FDA-approved oral progesterone capsules: 300-400 mg daily for 10 days has been studied for secondary amenorrhea, with 73.8% achieving withdrawal bleeding 5
Clinical Application Algorithm
- Start oral micronized progesterone 300 mg daily within 24 hours of embryo transfer
- Continue through pregnancy test (typically day 12-14 post-transfer)
- If pregnancy test positive: Continue through at least day 30, often extended through first trimester
- If drowsiness occurs: Advise bedtime dosing
- Do not adjust dose based on mid-luteal progesterone levels—no evidence of benefit 4
The oral route at 300 mg daily provides effective luteal support with the convenience of oral administration, though patients should be counseled about increased drowsiness compared to vaginal routes 1, 2.